Detalhe da pesquisa
1.
Understanding factors influencing primary treatment with intradetrusor onabotulinumtoxinA versus augmentation cystoplasty in patients with spina bifida.
Neurourol Urodyn
; 42(6): 1431-1436, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249147